Attached files
| file | filename |
|---|---|
| EX-23.2 - EX-23.2 - Vincerx Pharma, Inc. | d117132dex232.htm |
| EX-10.3 - EX-10.3 - Vincerx Pharma, Inc. | d117132dex103.htm |
| EX-10.2 - EX-10.2 - Vincerx Pharma, Inc. | d117132dex102.htm |
| EX-10.1 - EX-10.1 - Vincerx Pharma, Inc. | d117132dex101.htm |
| EX-5.1 - EX-5.1 - Vincerx Pharma, Inc. | d117132dex51.htm |
| EX-4.2 - EX-4.2 - Vincerx Pharma, Inc. | d117132dex42.htm |
| EX-4.1 - EX-4.1 - Vincerx Pharma, Inc. | d117132dex41.htm |
| EX-3.1 - EX-3.1 - Vincerx Pharma, Inc. | d117132dex31.htm |
| S-1 - S-1 - Vincerx Pharma, Inc. | d117132ds1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement on Form S-1 of our report dated September 14, 2020 relating to the financial statements of Vincera Pharma, Inc., which is contained in that Prospectus. We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ WithumSmith+Brown, PC
January 29, 2021